Extracorporeal photopheresis: Is one ounce of blood enough? Case reports
Pediatric Blood & Cancer2023Vol. 71(3), pp. e30800–e30800
Citations Over Time
Abstract
Extracorporeal photopheresis (ECP) has proven effective in the treatment of several diseases, including acute and chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation. In its standard version, ECP requires leukapheresis to obtain a fraction of mononuclear cells. The possibility of using leukapheresis is limited by the requirements for vascular access and the somatic status of the patient. We have developed a new ECP method that does not require leukapheresis. This paper presents a description of two clinical cases of severe refractory GVHD treated by micro-ECP.
Related Papers
- → Clinical Results of Extracorporeal Photopheresis(2012)16 cited
- → Extracorporeal Photopheresis in Dermatology(2009)5 cited
- → MINI-PHOTOPHERESIS – A NON-LEUKAPHERESIS BASED EXTRACORPOREAL PHOTOPHERESIS: CLINICAL EXPERIENCE(2021)2 cited
- → Extracorporeal photopheresis: Is one ounce of blood enough? Case reports(2023)1 cited
- → Extracorporeal photopheresis: is one ounce of blood enough? Cases report(2023)